REGENERON PHARMACEUTICALS, INC. (Pharmaceutical Preparations)

Pharmaceutical Preparations

Filing Clarity monitors every SEC filing for REGENERON PHARMACEUTICALS, INC. — Form 4 insider transactions, 8-K material events, and quarterly reports — and delivers plain-English signals with historical context.

Recent SEC filing signals

Filing Clarity delivers plain-English signals for each new filing, with historical context showing what changed from prior periods.

Earnings SynthesisREGENERON PHARMACEUTICALS, INC. Q2-2026: "second consecutive quarter of double-digit growth" First appearance; explic…2026-08-17

Earnings SynthesisREGENERON PHARMACEUTICALS, INC. Q2-2026: "productive early discussions" First appearance regarding potential expansio…2026-08-17

Earnings SynthesisREGENERON PHARMACEUTICALS, INC. Q2-2026: "productive early discussions" First appearance regarding Sanofi collaborati…2026-08-17

Earnings SynthesisREGENERON PHARMACEUTICALS, INC. Q4-2025: "best-in-class" Increased frequency; used to describe pozelimab (C5 antibody…2026-08-17

Earnings SynthesisREGENERON PHARMACEUTICALS, INC. Q1-2026: "Most-Favored-Nation Pricing agreement" First appearance; reflects new gover…2026-08-17

Ecosystem

Amgen (competitor)Pfizer (competitor)Johnson and Johnson (competitor)Eli Lilly And Company (competitor)Merck and Co Inc (competitor)Sanofi (customer)

Monitor REGN with Filing Clarity

Plain-English signals for every REGN SEC filing. Free during our testing period — no credit card required.

Add REGN to my watchlist →

What is an 8-K? How to read Form 4 Pricing